Clinical Evaluation of Cholecystokinin-A- Receptor Antagonist (Loxiglumide) for the Treatment of Acute Pancreatitis

Publisher： Karger

E-ISSN： 1421-9867|60|1|81-85

ISSN： 0012-2823

Source： Digestion, Vol.60, Iss.1, 1999-03, pp. : 81-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism of Cholecystokinin-A- Receptor Antagonist on Human Pancreatic Exocrine Secretion

By  

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 75-80

Karger

Access to resources Recommend Favorite

Role of Cholecystokinin in the Development and Progression of Acute Pancreatitis and the Potential of Therapeutic Application of Cholecystokinin Receptor Antagonists

By  

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 69-74

Karger

Access to resources Recommend Favorite

Therapeutic Effects of Loxiglumide on Experimental Acute Pancreatitis Using Various Models

By  

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 64-68

Karger

Access to resources Recommend Favorite

Potential Role of Cholecystokinin in the Development of Acute Pancreatitis

By  

Digestion, Vol. 60, Iss. 1, 1999-03 ,pp. : 61-63

Karger

Access to resources Recommend Favorite

Continuous Infusion of Cholecystokinin Leads to Down-Regulation of the Cholecystokinin-A Receptor in the Rat Pancreas

By Ohlsson   K. Borg   H. Mulder   J. F. Rehfeld   J. Axelson   F. Sundler B.  

Scandinavian Journal of Gastroenterology, Vol. 35, Iss. 6, 2000-07 ,pp. : 612-618

Informa Healthcare

Access to resources Recommend Favorite